Literature DB >> 2997379

Hit-and-run neutralization of poliovirus.

P Brioen, B Rombaut, A Boeyé.   

Abstract

At physiological ionic strength, monoclonal antibody 35-1f4 has previously been shown to neutralize poliovirus type 1 by antibody-mediated polymerization. At low ionic strength, this antibody neutralized the virus by a hit-and-run mechanism: the virions were converted to non-infectious, empty capsids devoid of antibodies. These empty capsids resembled those formed by thermal denaturation of native polio virions in their sedimentation coefficient (80S), antigenicity (H) and isoelectric pH (6.3).

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2997379     DOI： 10.1099/0022-1317-66-11-2495

Source DB:  PubMed          Journal:  J Gen Virol        ISSN： 0022-1317            Impact factor:   3.891


  11 in total

1.  Combined cell culture enzyme-linked immunosorbent assay for quantification of poliovirus neutralization- relevant antibodies.

Authors:  A F Wahby
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

2.  Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein.

Authors:  Margarita Magro; David Andreu; Paulino Gómez-Puertas; José A Melero; Concepción Palomo
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

3.  Inhibition of rhinovirus attachment by neutralizing monoclonal antibodies and their Fab fragments.

Authors:  R J Colonno; P L Callahan; D M Leippe; R R Rueckert; J E Tomassini
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

4.  Antibody-induced uncoating of human rhinovirus B14.

Authors:  Yangchao Dong; Yue Liu; Wen Jiang; Thomas J Smith; Zhikai Xu; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-10       Impact factor: 11.205

5.  Relationship between poliovirus neutralization and aggregation.

Authors:  A A Thomas; R Vrijsen; A Boeyé
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

6.  Mechanism of action and capsid-stabilizing properties of VHHs with an in vitro antipolioviral activity.

Authors:  Lise Schotte; Mike Strauss; Bert Thys; Hadewych Halewyck; David J Filman; Mihnea Bostina; James M Hogle; Bart Rombaut
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

7.  Monoclonal antibodies that disrupt poliovirus only at fever temperatures.

Authors:  I Delaet; A Boeyé
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

8.  Mechanisms of human immunodeficiency virus Type 1 (HIV-1) neutralization: irreversible inactivation of infectivity by anti-HIV-1 antibody.

Authors:  J S McDougal; M S Kennedy; S L Orloff; J K Nicholson; T J Spira
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

9.  Postabsorption neutralization of poliovirus.

Authors:  R Vrijsen; A Mosser; A Boeyé
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody.

Authors:  T J Smith; N H Olson; R H Cheng; H Liu; E S Chase; W M Lee; D M Leippe; A G Mosser; R R Rueckert; T S Baker
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.